Ireland’s largest indigenous pharmaceutical manufacturer of both medical and veterinary products today announced that it has appointed Abi Donald as Head of UK for its animal health divisions within the UK. Abi will be responsible for leading sales, marketing, and product development of Chanelle Pharma’s Animal Health business across the UK.
Announcing Abi’s appointment, Kara Walsh, Chief People Officer at Chanelle Pharma, said: “We are delighted Abi has agreed to take on this very important role as Head of UK for Animal Health at Chanelle Pharma. Abi is a purpose-driven leader who brings a wealth of experience and has an impressive track record of building high-performing teams and driving results for the business. We look forward to working with her to build shareholder value in the next exciting phase of Chanelle Pharma’s development in the UK, one of our key markets.”
Commenting on the appointment, Abi Donald, Head of UK at Chanelle Pharma UK, said: “This is a very exciting time for Chanelle Animal Health, with a thriving commercial portfolio to support our customers, partners, and distributors. I am thrilled to take on the leadership role at Chanelle Pharma UK where I get to work alongside an exceptionally talented team. It is so rewarding to be part of an organisation that fosters a customer-focused culture, powered by agility, a robust pipeline, and high-performing teams. I am looking forward to continuing to build Chanelle Pharma’s market share in animal health across the UK.”
About Abi Donald
Most recently, Abi served successfully as Head of the Retail division for Chanelle Pharma. Before joining Chanelle in 2019, Abi embarked on an MBA and held senior roles within other animal health companies, including Ceva and Zoetis. She held a variety of management positions across sales, marketing and operational divisions spanning over 15 years in the animal health ecosystem.
Abi lives in Gloucestershire, UK with her family that includes two dogs and a pony.
